Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Abdolsaleh Jafari

Abdolsaleh Jafari

University of Tasmania, Australia.

Title: Cost-effectiveness analysis of IEV drug Regimen versus ESHAP Drug regimen for the patients with Hodgkin and Non-Hodgkin’s Lymphoma in Iran

Biography

Biography: Abdolsaleh Jafari

Abstract

Chemotherapy for lymph node cancer is often composed of several drugs that are used in a treatment program. The aim of this study was to perform a cost-effectiveness analysis of IEV drug regimen (ifosfamide, epirubicin, and etoposide) versus ESHAP drug regimen (etoposide, methylprednisolone, high-dose cytarabine, and cisplatin) in patients with lymphoma in the south of Iran.